Enbrel
Sandoz announces biosimilar successes
December 8, 2015Manufacturing and Production American Society of Hematology, Enbrel, Neulasta, Sandoz, ash, biosimilars, etanercept, pegfilgrastim
Novartis’ biosimilars division Sandoz has announced progress in its biosimilars programme, with its version of Amgen’s Neulasta proving as effective …
Amgen agrees to $71m settlement over false advertising
August 19, 2015Sales and Marketing Amgen, Aranesp, Enbrel
Amgen has reached a $71 million settlement with 48 US states and the District of Columbia, to resolve allegations that …
Pfizer, Novartis and Celgene among late-stage psoriasis trial advances
March 23, 2015Sales and Marketing Celgene, Cosentyx, Enbrel, FDA, Novartis, Pfizer, otezla, psoriasis, tofacitinib
Pfizer bosses say they are confident of a positive FDA application for tofacitinib after announcing positive Phase III study results. …
Amgen to wield axe on 2,900 jobs
July 30, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, Enbrel, Prolia, job cuts
Amgen has announced this morning that it will make swingeing cuts in the US over the next two years as …
Profits drop for Pfizer
January 29, 2014Sales and Marketing Enbrel, Lipitor, Pfizer, Spiriva, Zoetis, q4
Pfizer’s turnover fell to $54.6 billion in 2013, a 6% drop year-on-year from $54.7 billion in 2012, but the group …
Mixed tale for Pfizer psoriasis drug
October 11, 2013Sales and Marketing Enbrel, Pfizer, psoriasis, tofacitinib
Pfizer has seen its novel, oral Janus kinase (JAK) inhibitor tofacitinib turn in a mixed showing in late-stage trials in …
Novartis compound beats Enbrel
July 9, 2013Sales and Marketing Enbrel, Novartis, Pfizer, skin
One of Novartis’ investigational drugs has beaten Pfizer’s Enbrel in a head-to-head Phase III psoriasis study and is on course …
Lipitor loss continues to hit Pfizer sales
July 31, 2012Sales and Marketing Enbrel, Lipitor, Pfizer, Prevnar, Q2
Pfizer has posted a loss in revenue for the second quarter as the firm continues to feel the impact of …
Forecasting future launch success
September 8, 2011Sales and Marketing Champix, Enbrel, forecast planning, forecasting
Pharmaceutical companies are moving into new and sometimes very different (often specialised) therapy areas, because of global market conditions and …
Merck to develop biosimilar of Pfizer’s Enbrel
June 15, 2011Research and Development, Sales and Marketing Enbrel, Merck & Co, biosimilar
Merck & Co is to develop its own version of Pfizer’s ageing arthritis drug Enbrel with a South Korean manufacturer. …
Digital Pharma: Pfizer, Enbrel and UK Google Adwords
October 22, 2010Medical Communications ABPI Code of Practice, Digital Pharma blog, Enbrel, Google Adwards, PMCPA, Pfizer, pharma SEO
Pfizer is using Google Adwords in the UK to promote an online eCongress for healthcare professionals interested in its arthritis …
NICE re-thinks arthritis guidance
June 25, 2010Sales and Marketing Enbrel, Humira, MabThera, NICE, Orencia, Remicade, TNF, rheumatoid arthritis
NICE has approved five rheumatoid arthritis treatments in certain circumstances after treatment with a tumour necrosis factor inhibitor has failed. …
Patients on Enbrel work longer, says study
September 7, 2009Research and Development, Sales and Marketing Enbrel, RA
Rheumatoid arthritis patients taking Enbrel are able to keep working for longer, according to a new study comparing its affects …
